GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeNeuro SA (CHIX:GNROp) » Definitions » Deferred Policy Acquisition Costs

GeNeuro (CHIX:GNROP) Deferred Policy Acquisition Costs


View and export this data going back to 2020. Start your Free Trial

What is GeNeuro Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


GeNeuro Business Description

Industry
Traded in Other Exchanges
N/A
Address
3 chemin du Pre-Fleur, Plan-les-Ouates, Geneva, CHE, 1228
GeNeuro SA is a clinical-stage biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases. The company's therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family (W-ENV).